December 2, 2024: Attorneys Name Six Defendants In Request to Create a Depo-Provera MDL Attorneys representing 22 women have filed federal lawsuits against 6 manufacturers of Depo-Provera and its generic equivalents (medroxyprogesterone acetate)
Forward and reverse catalysis and product sequestration by human glutathione S-transferases in the reaction of GSH with dietary aralkyl isothiocyanates
PubMed Central, Hinz, Marty, et al
Q: Will my results be the same as the clinical trials
Nausea is classified as 'very common' (affecting more than 1 in 10 people), occurring in approximately 15-20% of patients, whilst vomiting is 'common' (affecting up to 1 in 10 people), reported in around 5-9% of individuals taking the medication
Keep a food diary to identify your personal triggers